Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.


CSE:PHRX - Post by User

Post by SamRothsteinon Dec 17, 2020 10:35am
95 Views
Post# 32127686

one announcement is all it is going to take

one announcement is all it is going to takeBUZZ has market cap of 20 Mil, one of the lowest in this space.   They have some cash flow from their MJ distribution license in Germany, with that license having the potential to let them sell shrooms etc.  They have 1 smart shop, soon to be more (this is the biggest thing I am waiting on announcement about).  They have partnership with TRIP.  They have 4.24 Mil TRIP shares and 4.24 TRIP warrants.   They have Terry Booth as chairman.  Yes I know everthing didn't work out in the end for Aurora, but you could say that about most cannabis companies, and granted it was worse at Aurora.  But to me it is a no brainer that having him advising you in this space is very much a net positive.  If the worst that happens is that he helps grow BUZZ twentyfold and then it blows up like Aurora (along with others in the space)  I am AOK with that.  That is the normal cycle of any new industry.  Excess then consolidation.   I've seen arguments on this board that the CEO and insiders are trying to make themselves rich by pumping this stock.  My response is so what.  Isn't that their job?  I hope they get richer.  If they get richer the other shareholders get richer.  All it is going to take is one concrete announcement on the progression of their business plans, and you will be wishing you could still get shares in the $.10 range.   I think the run in this sector is just getting started.  I am not saying that BUZZ is best in sector at this moment, but I think it is a good value at this price, and their TRIP shares and warrants give it a bit of safety net.
<< Previous
Bullboard Posts
Next >>